Identifying the most important research, policy and practice questions for substance use, problematic alcohol use and behavioural addictions in autism (SABA-A): A priority setting partnership.


Journal

Comprehensive psychiatry
ISSN: 1532-8384
Titre abrégé: Compr Psychiatry
Pays: United States
ID NLM: 0372612

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 23 03 2023
revised: 09 05 2023
accepted: 14 05 2023
medline: 19 6 2023
pubmed: 22 5 2023
entrez: 21 5 2023
Statut: ppublish

Résumé

Autistic people are more likely to report problematic alcohol and other substance use when compared to the general population. Evidence suggests that up to one in three autistic adults may have an alcohol or other substance use disorder (AUD/SUD), although the evidence base for behavioural addictions is less clear. Autistic people may use substances or engage in potentially addictive behaviours as a means of coping with social anxiety, challenging life problems, or camouflaging in social contexts. Despite the prevalence and detrimental effects of AUD, SUD and behavioural addictions in community samples, literature focusing on the intersection between autism and these conditions is scarce, hindering health policy, research, and clinical practice. We aimed to identify the top 10 priorities to build the evidence for research, policy, and clinical practice at this intersection. A priority-setting partnership was used to address this aim, comprising an international steering committee and stakeholders from various backgrounds, including people with declared lived experience of autism and/or addiction. First, an online survey was used to identify what people considered key questions about Substance use, alcohol use, or behavioural addictions in autistic people (SABA-A). These initial questions were reviewed and amended by stakeholders, and then classified and refined to form the final list of top priorities via an online consensus process. The top ten priorities were identified: three research, three policy, and four practice questions. Future research suggestions are discussed.

Sections du résumé

BACKGROUND BACKGROUND
Autistic people are more likely to report problematic alcohol and other substance use when compared to the general population. Evidence suggests that up to one in three autistic adults may have an alcohol or other substance use disorder (AUD/SUD), although the evidence base for behavioural addictions is less clear. Autistic people may use substances or engage in potentially addictive behaviours as a means of coping with social anxiety, challenging life problems, or camouflaging in social contexts. Despite the prevalence and detrimental effects of AUD, SUD and behavioural addictions in community samples, literature focusing on the intersection between autism and these conditions is scarce, hindering health policy, research, and clinical practice.
METHODS METHODS
We aimed to identify the top 10 priorities to build the evidence for research, policy, and clinical practice at this intersection. A priority-setting partnership was used to address this aim, comprising an international steering committee and stakeholders from various backgrounds, including people with declared lived experience of autism and/or addiction. First, an online survey was used to identify what people considered key questions about Substance use, alcohol use, or behavioural addictions in autistic people (SABA-A). These initial questions were reviewed and amended by stakeholders, and then classified and refined to form the final list of top priorities via an online consensus process.
OUTCOMES RESULTS
The top ten priorities were identified: three research, three policy, and four practice questions. Future research suggestions are discussed.

Identifiants

pubmed: 37210935
pii: S0010-440X(23)00030-5
doi: 10.1016/j.comppsych.2023.152393
pmc: PMC7614597
mid: EMS175735
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

152393

Subventions

Organisme : Wellcome Trust
ID : 110049
Pays : United Kingdom

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Julia M A Sinclair (JMA)

Faculty of Medicine, University of Southampton, UK.

Betul Aslan (B)

Faculty of Medicine, University of Southampton, UK.

Roberta Agabio (R)

Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Italy; Neuroscience Institute, Section of Cagliari, National Research Council, Italy.

Amith Anilkumar (A)

Faculty of Medicine, University of Southampton, UK.

Mark Brosnan (M)

Centre for Applied Autism Research, University of Bath, UK.

Ed Day (E)

Institute of Mental Health, University of Birmingham, UK.

Nicki A Dowling (NA)

School of Psychology, Deakin University, Geelong, Australia; Melbourne Graduate School of Education, University of Melbourne, Australia.

Chelsey Flood (C)

University of the West of England, UK.

Jon E Grant (JE)

Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.

Robyn Halliday (R)

Expert by Experience, UK.

Björn Hofvander (B)

Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Denmark.

Leesa Howes (L)

Human Kind, UK.

Rachel Moseley (R)

Department of Psychology, Bournemouth University, Poole, UK.

Bronwyn Myers (B)

Curtin enAble Institute, Faculty of Health sciences, Curtin University, Perth, Western Australia, Australia; Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research council, South Africa; Division of Addiction Psychiatry, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Vincent O'Connor (V)

School of Biological Sciences, University of Southampton, UK.

Gabriel Shaya (G)

Turning Point, UK.

Shane Thomas (S)

Vice Chancellor's Office, Federation University, Australia; Centre for Research on Ageing, Health and Wellbeing, Australian National University, Australia.

Janine Robinson (J)

Chitra Sethia Autism Centre, Cambridgeshire and Peterborough NHS Foundation Trust, Fulbourn, Cambridge, UK.

Samuel R Chamberlain (SR)

Faculty of Medicine, University of Southampton, UK; Southern Health NHS Foundation Trust, Southampton, UK. Electronic address: srchamb@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH